Utah has one of the nation's lowest rates of prescriptions for anti-obesity GLP-1 drugs like Wegovy and Ozempic — but their ...

"Palatin concludes Phase II trial of combination therapy for obesity" was originally created and published by Clinical Trials ...

New GLP-1RA weight loss drugs like Like Ozempic and Wegovy have become extremely popular in recent months but researchers ...

FRIDAY, Feb. 7, 2025 (HealthDay News) -- Add surgical tweaks to fix so-called " Ozempic face" to the list of top trending ...

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...

Evaluate’s latest analysis forecasts an $82 billion increase in major product revenues in 2025 – the largest annual growth ...

Artificial intelligence and GLP-1 weight-loss shots are getting ads alongside traditional Super Bowl fare like fast food and ...

With Dry January firmly behind us, many adults are prompted to reassess their relationship with alcohol. Alcohol Change, the UK charity behind the popular Dry January initiative, found that 30% of men ...

New research explores the wide world of the positives, and potential drawbacks, of new obesity medications. And each brings a new consideration for physicians.

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

Following his massive 55-kilo transformation, Ram Kapoor claimed he was flooded with questions on whether he took any ...

Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...